According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

On April 10, 2024, the U.S. Department of Justice announced it had filed a complaint against Regeneron under the False Claims Act. According to the DOJ, the Company failed to report millions of ...

Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

U.S. Capital Wealth Advisors LLC grew its stake in shares of American International Group, Inc. (NYSE:AIG – Free Report) by ...

U.S. Capital Wealth Advisors LLC lifted its holdings in shares of Eastman Chemical (NYSE:EMN – Free Report) by 4.3% during the 4th quarter, according to its most recent Form 13F filing with the ...

The adjusted risk for COPD was elevated among adults who identified as regular cigarette smokers before age 15 years, ...

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...